Infliximab in the treatment of refractory posterior uveitis
- 31 July 2003
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 110 (7), 1449-1453
- https://doi.org/10.1016/s0161-6420(03)00406-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Immunopathology of the Noninfectious Posterior and Intermediate UveitidesSurvey of Ophthalmology, 2001
- Effect of infliximab on threatening panuveitis in Behçet's diseaseThe Lancet, 2001
- Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical UveitisOphthalmic Research, 2001
- Effect of infliximab on sight-threatening panuveitis in Behcet's diseaseThe Lancet, 2001
- Etanercept therapy in children with treatment-resistant uveitisArthritis & Rheumatism, 2001
- Cytokine gene expression in different strains of mice with endotoxin-induced uveitis (EIU)Ocular Immunology and Inflammation, 2000
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialThe Lancet, 1999
- Immunopathogenic Mechanisms in Intraocular InflammationPublished by S. Karger AG ,1999
- Autoimmunity and autoimmune disease of the eye.Published by S. Karger AG ,1999
- Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1998